Manulife (Manufacturers Life Insurance)’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-18,120
| Closed | -$683K | – | 3378 |
|
|
2021
Q1 | $683K | Sell |
18,120
-735
| -4% | -$18.3K | ﹤0.01% | 2103 |
|
|
2020
Q4 | $321K | Buy |
+18,855
| New | +$236K | ﹤0.01% | 2477 |
|
|
2020
Q3 | – | Sell |
-17,573
| Closed | -$118K | – | 2957 |
|
|
2020
Q2 | $118K | Sell |
17,573
-7,344
| -29% | -$30.3K | ﹤0.01% | 2701 |
|
|
2020
Q1 | $57K | Buy |
24,917
+2,640
| +12% | +$11.2K | ﹤0.01% | 2717 |
|
|
2019
Q4 | $102K | Sell |
22,277
-1,217
| -5% | -$4.82K | ﹤0.01% | 2796 |
|
|
2019
Q3 | $100K | Hold |
23,494
| – | – | ﹤0.01% | 2820 |
|
|
2019
Q2 | $142K | Buy |
23,494
+570
| +2% | +$5.45K | ﹤0.01% | 2793 |
|
|
2019
Q1 | $307K | Buy |
22,924
+1,091
| +5% | +$12.4K | ﹤0.01% | 2259 |
|
|
2018
Q4 | $203K | Sell |
21,833
-1,367
| -6% | -$16.3K | ﹤0.01% | 2319 |
|
|
2018
Q3 | $323K | Sell |
23,200
-2,575
| -10% | -$38.3K | ﹤0.01% | 2510 |
|
|
2018
Q2 | $407K | Buy |
25,775
+743
| +3% | +$13K | ﹤0.01% | 2560 |
|
|
2018
Q1 | $430K | Buy |
25,032
+3,782
| +18% | +$73.8K | ﹤0.01% | 2440 |
|
|
2017
Q4 | $466K | Buy |
21,250
+299
| +1% | +$9.62K | ﹤0.01% | 2368 |
|
|
2017
Q3 | $857K | Sell |
20,951
-498
| -2% | -$15.6K | ﹤0.01% | 1906 |
|
|
2017
Q2 | $646K | Buy |
21,449
+397
| +2% | +$12.4K | ﹤0.01% | 2100 |
|
|
2017
Q1 | $761K | Buy |
21,052
+2,527
| +14% | +$111K | ﹤0.01% | 1902 |
|
|
2016
Q4 | $928K | Buy |
18,525
+66
| +0.4% | +$3.47K | ﹤0.01% | 1709 |
|
|
2016
Q3 | $969K | Buy |
18,459
+79
| +0.4% | +$3.77K | ﹤0.01% | 1664 |
|
|
2016
Q2 | $760K | Buy |
18,380
+3,060
| +20% | +$133K | ﹤0.01% | 1774 |
|
|
2016
Q1 | $610K | Buy |
15,320
+834
| +6% | +$28.7K | ﹤0.01% | 1871 |
|
|
2015
Q4 | $601 | Buy |
14,486
+135
| +0.9% | +$4.53K | ﹤0.01% | 1912 |
|
|
2015
Q3 | $221 | Buy |
14,351
+464
| +3% | +$9.97K | ﹤0.01% | 2572 |
|
|
2015
Q2 | $345 | Buy |
13,887
+312
| +2% | +$6.95K | ﹤0.01% | 2391 |
|
|
2015
Q1 | $310 | Buy |
13,575
+2,231
| +20% | +$56.3K | ﹤0.01% | 2409 |
|
|
2014
Q4 | $306 | Buy |
11,344
+643
| +6% | +$11.1K | ﹤0.01% | 2337 |
|
|
2014
Q3 | $126 | Sell |
10,701
-583
| -5% | -$7.36K | ﹤0.01% | 2965 |
|
|
2014
Q2 | $176K | Buy |
11,284
+9,198
| +441% | +$132K | ﹤0.01% | 2823 |
|
|
2014
Q1 | $41 | Buy |
2,086
+1,957
| +1,517% | +$33.2K | ﹤0.01% | 3238 |
|
|
2013
Q4 | $2 | Buy |
+129
| New | +$1.6K | ﹤0.01% | 3688 |
|
Manulife (Manufacturers Life Insurance)'s FPRX Position: Q2 2021 in Review
Manulife (Manufacturers Life Insurance) sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 18,120 shares — an estimated $683K sold.
Manulife (Manufacturers Life Insurance) first reported a position in FPRX in Q4 2013 and held it in 29 quarters. The position peaked at $969K in Q3 2016. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- Manulife (Manufacturers Life Insurance) reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 18,120 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $683K.
- Manulife (Manufacturers Life Insurance) first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and held it in 29 quarters.
- Manulife (Manufacturers Life Insurance)'s Five Prime Therapeutics, Inc. position peaked at $969K in Q3 2016.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2021, filed 12 Aug 2021.